News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Summit Therapeutics Inc. - Common Stock
(NQ:
SMMT
)
18.70
-0.31 (-1.63%)
Streaming Delayed Price
Updated: 2:31 PM EST, Jan 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Summit Therapeutics Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Summit Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results & Operational Progress Call on February 24, 2025
February 18, 2025
From
Summit Therapeutics Inc.
Via
Business Wire
3 Stocks That Could Trounce the Market in 2025
↗
February 17, 2025
Via
The Motley Fool
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 14, 2025
From
Summit Therapeutics Inc.
Via
Business Wire
Is Summit Therapeutics a Millionaire Maker?
↗
February 09, 2025
Via
The Motley Fool
2 Stocks That Could Soar Again in 2025
↗
February 08, 2025
Via
The Motley Fool
Why Summit Therapeutics Rocketed 584% in 2024
↗
January 15, 2025
Via
The Motley Fool
Where Will Summit Therapeutics Be in 5 Years?
↗
December 20, 2024
Via
The Motley Fool
Jim Cramer Says AppFolio Is A 'Good One,' But Summit Therapeutics? 'Can't Go There'
↗
February 03, 2025
On CNBC's "Mad Money Lightning Round," Jim Cramer said Summit Therapeutics is "obviously just a very big spec."
Via
Benzinga
Up More Than 500% in 12 Months, Is It Too Late to Buy Summit Therapeutics Stock?
↗
January 30, 2025
Via
The Motley Fool
Netflix, Palantir And Moderna Are Among Top 12 Large Cap Gainers Last Week (Jan 20-Jan 24): Are The Others In Your Portfolio?
↗
January 26, 2025
12 large-cap stocks saw significant gains last week, including Summit Therapeutics, Rocket Lab, Moderna, and Netflix. Analysts raised price forecasts.
Via
Benzinga
3 Unstoppable Stocks to Buy That Wall Street Thinks Will Soar More Than 35%
↗
January 23, 2025
Via
The Motley Fool
How Is The Market Feeling About Summit Therapeutics?
↗
December 13, 2024
Via
Benzinga
Why Summit Therapeutics Stock Is Jumping Today
↗
January 21, 2025
Via
The Motley Fool
8 Health Care Stocks Whale Activity In Today's Session
↗
January 20, 2025
Via
Benzinga
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 16, 2025
From
Summit Therapeutics Inc.
Via
Business Wire
BioNTech Positioned For Solid Growth Amid Oncology Transition: Analyst
↗
January 10, 2025
Truist rates BioNTech a Buy, citing its shift to oncology with BNT327 leading the way. Key data updates and growth catalysts are expected by 2025.
Via
Benzinga
This Levi Strauss Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
↗
January 08, 2025
Via
Benzinga
Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over 300% Stock Upside
↗
January 07, 2025
Jefferies upgrades Instil Bio to "Buy" with a $52 target, anticipating significant growth for PD-(L)1xVEGF class and SYN2510's potential in cancer treatments.
Via
Benzinga
Summit Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 07, 2025
From
Summit Therapeutics Inc.
Via
Business Wire
Prediction: These 3 Healthcare Stocks Will Soar in 2025
↗
January 04, 2025
Via
The Motley Fool
3 Stocks That Could Be Monster Winners in 2025
↗
December 29, 2024
Via
The Motley Fool
3 Stocks That Could Turn $1,000 into $5,000 by 2030
↗
December 20, 2024
Via
The Motley Fool
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
↗
December 18, 2024
Via
The Motley Fool
2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street
↗
December 15, 2024
Via
The Motley Fool
Investing $5,000 in Each of These 3 Stocks at the Start of 2024 Would Have Created a Portfolio Worth More Than $100,000 Today
↗
December 14, 2024
Via
The Motley Fool
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 13, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Why Summit Therapeutics Stock Rocketed 6% Higher on Friday
↗
December 06, 2024
Via
The Motley Fool
Billionaire Ken Griffin Is Selling Palantir and Buying a Stock Wall Street Expects to Rocket 139% Higher
↗
December 02, 2024
Via
The Motley Fool
Warning: This Skyrocketing Stock Has a Hidden Risk
↗
November 30, 2024
Via
The Motley Fool
Summit Therapeutics to Present at Upcoming Investor Conferences
November 26, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
